On Wednesday, MeadWestvaco Corporation (NYSE:MWV)’s shares gained 2.53%, and closed at $49.08, as a global leader in packaging and packaging solutions, will release its first quarter 2015 results on Wednesday, April 29, 2015, before the market opens. The news release and slides for the results will be accessible on MWV’s website at www.mwv.com.
The corporation will host its first quarter 2015 results conference call on Wednesday, April 29, 2015, at 10 a.m. (EDT) with access accessible via Internet and telephone.
MeadWestvaco Corporation provides packaging solutions to the healthcare, beauty and personal care, food, beverage, home and garden, tobacco, and agricultural industries worldwide. The corporation operates through Food & Beverage; Home, Health & Beauty; Industrial; Specialty Chemicals; and Community Development and Land Administration segments.
Fortress Investment Group LLC (NYSE:FIG)’s shares jumped 2.52%, and settled at $8.55, during the last trading session on Wednesday, after TriPlay, the next-generation personal cloud corporation, and the developer of MyMusicCloud and MyDigipack, declared that it has secured $11 million of financing from funds managed by associates of Fortress Investment Group LLC (FIG) a leading, highly diversified global investment firm with about $67 billion in assets under administration as of December 31, 2014, in addition to from existing investors, Kenges Rakishev and Tamir Koch, TriPlay founder and CEO.
TriPlay will use this latest round of funds to support its marketing efforts, accelerate its research and development and grow their existing base of over one million users of its open, next generation personal cloud services. MyMusicCloud and MyDigipack are universal applications above the cloud that allow users free unlimited storage and access to their music, photos and videos on any device, operating system, file format and network anywhere in the world.
Fortress Investment Group LLC is a publicly owned investment manager. The firm provides its services to pooled investment vehicles, pension and profit sharing plans, corporations, institutional managed accounts and structured products, banking or thrift institutions, investment companies, charitable organizations, and state or municipal government entities.
At the end of Wednesday’s trade, The Medicines Company (NASDAQ:MDCO)’s shares climbed 2.47%, and closed at $28.19, after Medicines Company declared that it has settled its litigation with Sun Pharmaceutical Industries Ltd. (Sun Pharma) and certain of its auxiliaries regarding MDCO’s U.S. Patent No. 7,582,727 and U.S. Patent No. 7,598,343 covering Angiomax® (bivalirudin). The patents are listed in the Orange Book and expire on July 27, 2028.
As a result of the settlement, MDCO will permit a Sun Pharma partner to market a generic bivalirudin product in the United States on June 30, 2019, or earlier in certain limited circumstances. This settlement validates MDCO’s patents while allowing a Sun Pharma partner to enter the market with its generic product.
The other terms of the contract are confidential. The contract will be presented to the applicable governmental agencies for review.
The Medicines Corporation provides medicines for patients in acute and intensive care hospitals worldwide. The corporation markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for use in patients undergoing percutaneous coronary intervention; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; Minocin IV, an antibiotic for the treatment of infections due to gram-negative bacteria; Orbactiv for the treatment of acute bacterial skin and skin structure infections; PreveLeak, a mechanical vascular and surgical sealant; ready-to-use formulation of Argatroban for the treatment of thrombosis; and Recothrom, a human recombinant thrombin used as an aid to hemostasis, in addition to acute care generic products for acute cardiovascular, surgery and perioperative care, and serious infectious diseases.
Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY), ended its Wednesday’s trading session with 2.45% gain, and closed at $31.39, as an owner and operator of dining and entertainment venues, declared financial results for its fourth quarter and full year 2014, which ended on February 1, 2015. The Corporation also issued guidance for the full year 2015.
Key highlights from the fourth quarter 2014 contrast to the fourth quarter 2013 comprise:
- Total proceeds raised 20.8% to $207.1 million from $171.4 million.
- Comparable store sales raised 10.5%.
- Opened three stores in the fourth quarter of fiscal 2014.
- Adjusted EBITDA, a non-GAAP measure, raised 28.1% to $51.5 million from $40.2 million. As a percentage of total proceeds, Adjusted EBITDA raised about 140 basis points to 24.9%.
- Net revenue of $14.7 million, or $0.34 per diluted share, contrast to net revenue of $4.9 million, or $0.14 per diluted share, for the fourth quarter last year.
- Pro forma net revenue, a non-GAAP measure, was $14.1 million, or $0.33 per diluted share, contrast to $7.7 million, or $0.18 per diluted share, in the fourth quarter 2013.
Dave & Buster’s Entertainment, Inc. owns and operates venues that combine dining and entertainment in North America for adults and families. It offers food and beverage items combined with an assortment of entertainment attractions, counting skill and sports-oriented redemption games, video games, interactive simulators, and other traditional games.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
